ArticleCancer management and research2022

Retrospective Review of Efficacy and Safety of Anlotinib in Advanced Leiomyosarcoma: A Real-World Study.

Hanhui Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.